《滬深兩市》上證近平開深成微微高開1點 紫光股份高開2.5%
內地昨日(17日)新增本土確診病例127例。人行今日(18日)進行1,000億人民幣(下同)7天期逆回購操作,利率持平,單日淨投放900億元。人民幣兌美元中間價今上調78點,上證近平開深成微微高開。
上證綜指近平開報3,541點;深證成指微微高開1點或0.01%,報14,365點;滬深300近平開報4,766;創業板指微微低開1點或0.05%,報3,168點。
中資金融股無方向,工行(601398.SH)及建行(601939.SH)平開。
據統計第二大海外中國股基摩根基金上月大舉增持寧德時代(300750.SZ)及中國平安(601318.SH),兩股開市均平開;略被減持的隆基股份(601012.SH)開市跌0.5%。
紫光股份(000938.SZ)母企紫光集團重整計劃獲法院批準,股價開市升2.5%。
山西證券(002500.SZ)子公司涉樂視網虛假陳述案被提起訴,股價開市跌3%。(ta/k) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.